Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

Since the onset of COVID-19 pandemic, parallel opportunistic infections have also been
emerging as another disease spectrum. Among all these opportunistic infection …

Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …

Fungal co-infections are frequent in patients with coronavirus disease 2019 (COVID-19) and
can affect patient outcomes and hamper therapeutic efforts. Nonetheless, few studies have …

SUMMARY Coronavirus disease 2019 (COVID-19) is an acute viral illness caused by
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Opportunistic infections …

The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …

Background: Since the novel coronavirus disease (COVID-19) outbreak, the cases of COVID-
19 co-infections have been increasingly reported worldwide. Mucormycosis, an …

Mucormycosis, a serious and rare fungal infection, has recently been reported in COVID-19
patients worldwide. This study aims to map all the emerging evidence on the COVID-19 …

BACKGROUND: Till now, no meta-analysis is available to address the clinical profile, risk
factors, different interventions, and outcomes among COVID-19–associated rhino-orbito …

Background Acute invasive fungal sinusitis (AIFS) is an aggressive disease that requires
prompt diagnosis and multidisciplinary treatment given its rapid progression. However, there …